Topics

Companies Related to "Risk Amputation Higher With Microvascular Disease" [Most Relevant Company Matches] RSS

18:58 EDT 24th August 2019 | BioPortfolio

Here are the most relevant search results for "Risk Amputation Higher With Microvascular Disease" found in our extensive corporate database of over 50,000 company records.

Showing "Risk Amputation Higher With Microvascular Disease" Companies 1–25 of 3,900+

Relevant

Glycominds Ltd.

Glycominds, a commercial stage molecular diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease management tools and services with a distinctive focus on the Multiple Sclerosis market. Our proprietary tests allow physicians to help identify patients at a higher risk for more severe disease outcomes.


Higher One

Higher One Holdings, Inc. (NYSE: ONE) is a leading company focused on creating cost-saving efficiencies for higher education institutions and providing high-value services to students. Higher One offers a wide array of technological services on campus, ranging from streamlining the institution’s performance analytics and financial aid refund processes ...

Micro Medical Solutions

Micro Medical Solutions is on a mission to provide solutions to some of the most pressing unmet needs in microvascular intervention by helping to significantly reduce the rate of amputations, improve clinical outcomes and patient quality of life, and minimize the financial and human costs associated with the treatment of peripheral artery disease and criti...


South Asian Heart Center

The South Asian Heart Center, the first major non-profit devoted to combating the growing epidemic of heart disease among people from Bangladesh, India, Pakistan, Nepal, and Sri Lanka, has developed a unique preventative program. Offered at a minimal, subsidized cost, the Center assesses the risk for heart disease using an advanced screening process that k...

Eyenuk Inc.

Eyenuk Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology...

diaDexus

diaDexus, a privately held biotechnology company, is focused on the discovery, development, and commercialization of novel, patent protected diagnostic products with high clinical value.diaDexus’ lead product, the PLAC® test, is a blood test that measures the concentration of lipoprotein-associated phospholipase A2 (Lp-PLA2), a novel risk factor for coronary heart disease and ischemic stroke. T...

SENES Oak Ridge, Inc.,

SENES Oak Ridge, Inc., Center for Risk Analysis, founded in 1992, is committed to attaining the highest level of technical excellence and transparency in all its work. SENES Oak Ridge specializes in human health and ecological risk estimation, risk assessment, and risk communication.SENES offers comprehensive, multidisciplinary consulting services in areas related to human health and ecological ri...

Ohio Department of Higher Education

The Ohio Department of Higher Education (formerly known as the Ohio Board of Regents) is a Cabinet-level agency for the Governor of the State of Ohio that oversees higher education for the state. The agency’s main responsibilities include authorizing and approving new degree programs, managing state-funded financial aid programs and developing and adv...

Marathon Health

Marathon Health offers a proven population health risk management model for helping employers reduce the total cost of healthcare. Our approach integrates the best practices of onsite primary care, health assessment with risk identification, coaching and advocacy, and disease and condition management for individuals with identifiable and controllable risk factors. Together, these services create...

The Risk Authority Stanford

The Risk Authority Stanford (TRA Stanford) is a healthcare risk management consulting firm dedicated to transforming its clients’ risk management practices with cutting-edge solutions, unrivaled expertise, and quantifiable results. TRA Stanford’s origins are rooted within the Stanford University Medical Network, and it continues to provide all ...

PlaqueTec Ltd.

PlaqueTec offers a first-of-its-kind catheter technology for cardiologists to routinely assess inflammation in the coronary artery, and better understand residual inflammatory risk. It has been proven to detect inflammatory molecules across the site of coronary artery disease (CAD), and can discriminate between patients with greater and lesser levels of co...

The Lipoprotein(a) Foundation

Because approximately 63 million Americans have high Lipoprotein(a) and are at risk of premature cardiovascular disease, the vision for the foundation is: To live in a world where high Lipoprotein(a) is routinely diagnosed, treated and family screened. The mission is to prevent cardiovascular events due to high Lipoprotein(a) by diagnosing this inherited r...

VitreosHealth

VitreosHealth®, an innovative provider of predictive population risk analytics for care management and contract optimization leverages EMR, Claims & Demographics data for medical homes, physician groups, ACOs, hospital systems, IDNs, and shared savings programs. VitreosHealth® with its “ACO-in-a-Box” and “PCMH-in-a-Box” solutions deliver...

McGraw-Hill Higher Education

McGraw-Hill Higher Education, a unit of McGraw-Hill Education, is a premier provider of teaching and learning solutions for 21st century post-secondary and higher education markets worldwide. Through a comprehensive range of traditional and digital education content and tools, McGraw-Hill Higher Education empowers educators and prepares professionals and students of all ages to connect, learn and...

Cardiovascular Systems, Inc.

Cardiovascular Systems Inc., (CSI) (Nasdaq: CSII) based in St. Paul, Minn., is a medical device company focused on providing clinically proven, safe and effective interventional solutions for vascular disease. The company’s Diamondback 360® System removes calcified and fibrotic plaque in small and large peripheral vessels, and addresses many of the...

Venous Disease Coalition

The Venous Disease Coalition (VDC) is an alliance of more than 35 leading health professional societies and patient advocacy groups that have united around a common goal: To improve the survival rates and quality of life for individuals with, or at risk for, venous disease. The VDC plans to develop a national campaign to educate public and health care professionals in the U.S. about venous disease...

Origami Risk LLC

Origami Risk LLC was founded by industry veterans committed to designing intuitive web-based software that streamlines how risk, insurance and claims data is collected, analyzed and shared—ultimately helping users to be more productive and manage the total cost of risk for their organizations or for their clients. Origami Risk is consistently ranked b...

Pathway Medical Technologies Inc.

Pathway Medical Technologies, Inc. (Pathway), located in Redmond, Washington was founded in 1998 to design, develop and manufacture innovative medical devices intended for the treatment of arterial disease. The company’s initial focus is on peripheral artery disease (PAD).According to the American Heart Association, peripheral artery disease affects 8 – 12 million in the U.S. PAD prevalence in...

Premier, Inc

Premier members demonstrate every day that high quality hospitals can be cost-effective. We offer solutions in three areas where quality and financial performance are intimately linked: The healthcare supply chain; performance measurement and improvement; and insurance and risk management. Through Premier's solutions and knowledge-sharing across the alliance, members and clients benefit from:Lower...

The Risk Authority

The Risk Authority – Stanford (TRA) is an innovative healthcare risk management consulting firm dedicated to transforming their clients’ risk management practices with cutting-edge solutions, unrivaled industry expertise and quantifiable results. TRA’s origins are rooted within the Stanford University Medical Network. This connection continues toda...

Possis Medical

Possis Medical, Inc. is pioneering mechanical thrombectomy, i.e. the rapid, safe and effective removal of blood clots from native arteries and veins, as well as from synthetic and saphenous vein grafts. The Company currently has a portfolio of three FDA indications for use of its AngioJet® Rheolytic™ Thrombectomy System. The system has been used to treat over 250,000 patients in 1,400 locations...

Proximagen Neuroscience plc

Proximagen Neuroscience plc is a publicly traded neuroscience research company focused on drug development for neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease. Proximagen is building a compound pipeline to address the significant unmet medical needs of patients with neurodegenerative disease through its own discovery programme for novel, low risk therapeutic can...

Lipoprotein(a) Foundation

Based in San Carlos, California, the Lipoprotein(a) Foundation is a patient-advocacy, 501(c)(3) nonprofit organization. Because approximately 63 million Americans have high lipoprotein(a) and are at risk of premature cardiovascular disease, the vision for the foundation is to live in a world where high Lipoprotein(a) is routinely diagnosed, treated and fam...

Zillion

Zillion is the leading behavior architecture solutions company in the United States. Zillion’s technology emphasizes architecting individual choices providing the right nudge at the right time to assist individuals in forming a new behavior scaffolding. Since its commercial launch in 2014, Zillion has collected over 100 million data points from over 6...

Signet Laboratories Incorporated

Signet Laboratories, Inc is a medical biotechnology company focused in fields of cancer and infectious disease(Sepsis). Signet has developed proprietary antibody systems for the detection and management of breast and prostate cancer and Sepsis. Signet's patented technology will provide for determining risk in "normal patients who may be at increased risk for developing cancer at a time when proac...


More From BioPortfolio on "Risk Amputation Higher With Microvascular Disease"

Quick Search

Corporate Database Quicklinks